The FDA sent a letter to Eli Lilly scolding the drugmaker for Instagram ads it posted for its Type 2 diabetes drug Trulicity. In the letter, dated Jan. 19, the FDA said the ads do not adequately ...
FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicity
After neatly wrapping up concerns over a series of Emgality ads last month, Eli Lilly is back in hot water with the FDA's Office of Prescription Drug Promotion. The FDA gave Lilly a slap on the wrist ...
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will instead offer patients a link to ...
Eli Lilly is officially the first pharma to add pricing information to a TV commercial. The move—initially for Trulicity in a spot that debuted this week—will expand to its other TV-promoted drugs by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results